Consistently with the cell proliferation results, the SQ22536 pretreatment abrogated the carvone-induced phosphorylation of Cdc25B and CDK1 in B16F10 melanoma cells (Figure 6A,B). The gene discussed is CDC25B; the disease is melanoma.